China Pharma Holdings, Inc. - Understand $cphi stock

$CPHI Market Cap: $3.754 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$5.545M

TTM

Gross Margin

-45.47%

TTM

Net Earnings

-$4.744M

TTM

Current Assets

$3.739M

Q3 2024

Current Liabilities

$4.760M

Q3 2024

Current Ratio

78.55%

Q3 2024

Total Assets

$13.47M

Q3 2024

Total Liabilities

$6.937M

Q3 2024

Book Value

$6.528M

Q3 2024

Cash

$700.0K

Q3 2024

P/E

-0.7914

Nov 29, 2024 EST

Free Cash Flow

-$713.0K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$7.011M	$8.104M	$9.642M	$10.87M	$10.92M	$12.33M	$13.21M	$15.57M	$20.35M	$22.13M	$32.81M	$54.51M	$81.17M	$74.39M	$61.70M	$50.97M	$33.19M	$21.84M	$8.660M	$20.00K	$110.0K	$40.00K	$40.00K
YoY Change	-13.48%	-15.95%	-11.27%	-0.53%	-11.41%	-6.67%	-15.15%	-23.49%	-8.05%	-32.54%	-39.81%	-32.84%	9.11%	20.56%	21.05%	53.57%	51.97%	152.19%	43200.0%	-81.82%	175.0%	0.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$7.011M	$8.104M	$9.642M	$10.87M	$10.92M	$12.33M	$13.21M	$15.57M	$20.35M	$22.13M	$32.81M	$54.51M	$81.17M	$74.39M	$61.70M	$50.97M	$33.19M	$21.84M	$8.660M	$20.00K	$110.0K	$40.00K	$40.00K
Cost Of Revenue	$7.292M	$8.598M	$9.293M	$8.914M	$9.442M	$10.36M	$10.74M	$12.35M	$18.89M	$19.47M	$33.29M	$40.43M	$52.18M	$44.11M	$36.05M	$25.68M	$17.62M	$11.75M	$4.170M	$50.00K	$0.00	$0.00
Gross Profit	-$281.1K	-$493.9K	$349.3K	$1.953M	$1.482M	$1.975M	$2.469M	$3.219M	$1.465M	$2.668M	-$480.0K	$14.08M	$28.99M	$30.28M	$25.65M	$25.29M	$15.57M	$10.10M	$4.490M	-$30.00K	$110.0K	$110.0K
Gross Profit Margin	-4.01%	-6.09%	3.62%	17.97%	13.57%	16.02%	18.68%	20.67%	7.2%	12.05%	-1.46%	25.83%	35.71%	40.71%	41.57%	49.62%	46.91%	46.25%	51.85%	-150.0%	100.0%	275.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Selling, General & Admin	$2.007M	$2.963M	$2.853M	$4.153M	$4.645M	$5.771M	$6.874M	$7.389M	$16.34M	$36.42M	$16.44M	$7.720M	$7.156M	$5.582M	$3.040M	$5.560M	$3.320M	$1.470M	$250.0K	$90.00K	$270.0K	$750.0K	$750.0K
YoY Change	-32.27%	3.87%	-31.31%	-10.59%	-19.5%	-16.05%	-6.97%	-54.78%	-55.13%	121.51%	112.95%	7.88%	28.19%	83.63%	-45.32%	67.47%	125.85%	488.0%	177.78%	-66.67%	-64.0%	0.0%
% of Gross Profit			816.76%	212.67%	313.41%	292.22%	278.47%	229.57%	1115.59%	1364.83%		54.83%	24.69%	18.43%	11.85%	21.98%	21.32%	14.55%	5.57%		245.45%	681.82%
Research & Development	$240.1K	$185.9K	$319.0K	$378.0K	$229.6K	$172.4K	$90.47K	$366.0K	$961.9K	$2.799M	$1.680M	$440.0K
YoY Change	29.17%	-41.73%	-15.61%	64.59%	33.22%	90.54%	-75.28%	-61.95%	-65.63%	66.58%	281.82%
% of Gross Profit			91.32%	19.35%	15.49%	8.73%	3.66%	11.37%	65.68%	104.89%		3.13%
Depreciation & Amortization	$2.754M	$2.701M	$3.088M	$2.679M	$2.929M	$3.259M	$3.291M	$3.078M	$3.599M	$1.786M	$1.610M	$1.460M	$1.175M	$1.505M	$1.370M	$720.0K	$420.0K	$400.0K	$250.0K	$0.00	$70.00K	$80.00K	$80.00K
YoY Change	1.97%	-12.54%	15.24%	-8.51%	-10.12%	-0.99%	6.93%	-14.46%	101.5%	10.92%	10.27%	24.27%	-21.95%	9.87%	90.28%	71.43%	5.0%	60.0%		-100.0%	-12.5%	0.0%
% of Gross Profit			884.08%	137.2%	197.6%	165.01%	133.33%	95.64%	245.71%	66.93%		10.37%	4.05%	4.97%	5.34%	2.85%	2.7%	3.96%	5.57%		63.64%	72.73%
Operating Expenses	$2.471M	$3.055M	$3.210M	$4.531M	$4.875M	$5.943M	$6.965M	$7.412M	$15.66M	$39.15M	$18.12M	$7.580M	$7.264M	$6.088M	$3.030M	$5.560M	$3.320M	$1.470M	$240.0K	$90.00K	$270.0K	$760.0K	$760.0K
YoY Change	-19.13%	-4.82%	-29.16%	-7.05%	-17.97%	-14.67%	-6.03%	-52.67%	-60.0%	116.06%	139.05%	4.35%	19.33%	100.91%	-45.5%	67.47%	125.85%	512.5%	166.67%	-66.67%	-64.47%	0.0%
Operating Profit	-$2.752M	-$3.549M	-$2.861M	-$2.578M	-$3.393M	-$3.968M	-$4.496M	-$4.193M	-$14.20M	-$36.48M	-$18.60M	$6.500M	$22.03M	$24.66M	$22.62M	$19.73M	$12.25M	$8.630M	$4.250M	-$120.0K	-$160.0K	-$650.0K
YoY Change	-22.46%	24.07%	10.95%	-24.01%	-14.51%	-11.74%	7.22%	-70.46%	-61.09%	96.14%	-386.15%	-70.49%	-10.7%	9.04%	14.65%	61.06%	41.95%	103.06%	-3641.67%	-25.0%	-75.38%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Interest Expense	-$327.0K	$434.6K	-$539.0K	-$288.5K	-$294.2K	-$412.7K	-$474.9K	-$719.0K	-$1.045M	-$716.1K	-$340.0K	-$300.0K	-$255.2K	-$168.3K	-$120.0K	-$90.00K	-$210.0K	-$150.0K	-$190.0K	-$10.00K	-$50.00K	-$180.0K	-$180.0K
YoY Change	-175.24%	-180.64%	86.83%	-1.94%	-28.72%	-13.09%	-33.95%	-31.21%	45.97%	110.61%	13.33%	17.56%	51.67%	40.22%	33.33%	-57.14%	40.0%	-21.05%	1800.0%	-80.0%	-72.22%	0.0%
% of Operating Profit												-4.62%	-1.16%	-0.68%	-0.53%	-0.46%	-1.71%	-1.74%	-4.47%
Other Income/Expense, Net	-$327.0K	-$423.9K	-$539.0K								$0.00	-$140.0K	$300.0K	$470.0K	$0.00	-$100.0K	$610.0K	$110.0K	-$10.00K	$0.00	$0.00	$0.00
YoY Change	-22.85%	-21.36%									-100.0%	-146.67%	-36.17%		-100.0%	-116.39%	454.55%	-1200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Pretax Income	-$3.079M	-$3.973M	-$3.399M	-$2.867M	-$20.70M	-$10.86M	-$19.15M	-$8.874M	-$15.35M	-$39.47M	-$18.95M	$5.600M	$686.3K	$1.436M	$22.49M	$19.54M	$12.66M	$8.590M	$4.050M	-$510.0K	-$520.0K	-$1.100M	-$1.100M
YoY Change	-22.5%	16.87%	18.58%	-86.15%	90.62%	-43.3%	115.84%	-42.17%	-61.13%	108.3%	-438.39%	716.01%	-52.21%	-93.61%	15.1%	54.34%	47.38%	112.1%	-894.12%	-1.92%	-52.73%	0.0%
Income Tax	$0.00				$0.00	-$110.0K	$122.6K	$308.2K	$60.44K	$77.04K	$1.060M	$980.0K	-$3.442M	-$2.686M	$2.260M	$1.710M	-$160.0K	$0.00	$250.0K	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income												17.5%	-501.6%	-187.07%	10.05%	8.75%	-1.26%	0.0%	6.17%
Net Earnings	-$3.079M	-$3.973M	-$3.399M	-$2.867M	-$20.70M	-$10.75M	-$19.28M	-$9.183M	-$15.41M	-$39.55M	-$20.01M	$4.620M	$19.27M	$23.41M	$20.23M	$17.83M	$12.82M	$8.590M	$3.800M	-$510.0K	-$520.0K	-$1.100M	-$1.100M
YoY Change	-22.5%	16.87%	18.58%	-86.15%	92.57%	-44.23%	109.94%	-40.39%	-61.05%	97.65%	-533.12%	-76.02%	-17.7%	15.74%	13.46%	39.08%	49.24%	126.05%	-845.1%	-1.92%	-52.73%	0.0%
Net Earnings / Revenue	-43.91%	-49.02%	-35.26%	-26.38%	-189.51%	-87.18%	-145.91%	-58.97%	-75.7%	-178.69%	-60.99%	8.48%	23.74%	31.48%	32.79%	34.98%	38.63%	39.33%	43.88%	-2550.0%	-472.73%	-2750.0%	-2750.0%
Basic Earnings Per Share	-$0.91	-$0.76	-$0.74										$0.44	$0.54
Diluted Earnings Per Share	-$0.91	-$0.76	-$73.69K	-$65.72K	-$475.0K	-$246.7K	-$442.4K	-$210.7K	-$353.5K	-$907.6K	-$459.2K	$106.0K	$0.44	$0.54	$478.5K	$443.3K	$344.1K	$247.4K	$336.6K	-$894.7K	-$1.576M	-$3.929M	-$3.929M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Cash & Short-Term Investments	$1.424M	$2.030M	$4.859M	$957.7K	$1.075M	$1.187M	$2.030M	$2.666M	$6.249M	$5.296M	$6.000M	$4.000M	$4.100M	$3.700M	$3.600M	$6.900M	$1.800M	$700.0K	$500.0K	$0.00	$0.00	$0.00	$0.00
YoY Change	-29.86%	-58.22%	407.39%	-10.91%	-9.41%	-41.55%	-23.84%	-57.34%	17.99%	-11.74%	50.0%	-2.44%	10.81%	2.78%	-47.83%	283.33%	157.14%	40.0%
Cash & Equivalents	$1.424M	$2.030M	$4.859M	$957.7K	$1.075M	$1.187M	$2.030M	$2.666M	$6.249M	$5.296M	$6.000M	$4.000M	$4.100M	$3.700M	$3.600M	$6.900M	$1.800M	$700.0K	$500.0K	$0.00	$0.00	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$110.3K	$77.70K	$58.79K	$73.67K	$187.0K	$1.398M	$895.5K	$1.315M	$339.1K	$404.4K	$0.00	$1.000M	$600.0K	$500.0K	$300.0K	$500.0K	$0.00	$100.0K	$0.00
YoY Change	41.9%	32.17%	-20.2%	-60.61%	-86.62%	56.09%	-31.92%	287.82%	-16.13%		-100.0%	66.67%	20.0%	66.67%	-40.0%		-100.0%
Inventory	$3.733M	$2.948M	$3.340M	$3.705M	$3.589M	$5.055M	$6.407M	$7.311M	$9.663M	$15.32M	$24.70M	$36.40M	$30.40M	$20.40M	$14.20M	$13.10M	$14.40M	$10.30M	$5.800M
Prepaid Expenses
Receivables	$504.4K	$421.5K	$714.5K	$501.9K	$635.4K	$916.9K	$2.293M	$4.000M	$5.174M	$13.85M	$45.10M	$66.20M	$69.70M	$61.90M	$51.20M	$36.00M	$18.50M	$12.10M	$5.600M		$0.00	$0.00	$0.00
Other Receivables	$225.9K	$487.6K	$121.4K	$83.63K	$92.80K	$190.7K	$664.2K	$2.228M	$2.824M	$7.038M	$8.200M	$5.000M	$5.900M	$5.400M	$1.900M	$3.200M	$4.100M	$2.600M	$2.600M		$0.00	$0.00	$0.00
Total Short-Term Assets	$5.997M	$5.965M	$9.093M	$5.322M	$5.579M	$8.747M	$12.29M	$17.52M	$24.25M	$41.91M	$84.00M	$112.5M	$110.6M	$91.90M	$71.30M	$59.70M	$38.80M	$25.70M	$14.50M	$0.00	$0.00	$0.00	$0.00
YoY Change	0.54%	-34.41%	70.87%	-4.61%	-36.22%	-28.83%	-29.85%	-27.75%	-42.15%	-50.1%	-25.33%	1.72%	20.35%	28.89%	19.43%	53.87%	50.97%	77.24%
Property, Plant & Equipment	$7.217M	$10.01M	$13.41M	$15.61M	$16.45M	$19.29M	$23.54M	$24.97M	$29.39M	$33.88M	$30.20M	$9.000M	$6.300M	$6.400M	$6.700M	$6.700M	$2.600M	$2.700M	$2.800M		$0.00	$400.0K	$400.0K
YoY Change	-27.92%	-25.33%	-14.12%	-5.09%	-14.74%	-18.04%	-5.71%	-15.06%	-13.25%	12.19%	235.56%	42.86%	-1.56%	-4.48%	0.0%	157.69%	-3.7%	-3.57%			-100.0%	0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets					$0.00	$17.07M	$23.72M	$35.50M	$42.03M	$43.97M	$41.70M	$39.30M	$36.40M	$4.400M	$3.600M	$2.800M	$200.0K	$0.00	$100.0K
YoY Change					-100.0%	-28.05%	-33.17%	-15.54%	-4.41%	5.45%	6.11%	7.97%	727.27%	22.22%	28.57%	1300.0%		-100.0%
Total Long-Term Assets	$10.47M	$11.82M	$13.56M	$15.80M	$16.66M	$36.63M	$47.66M	$61.00M	$72.26M	$79.17M	$73.60M	$50.70M	$45.80M	$39.90M	$29.60M	$15.80M	$4.900M	$2.800M	$3.000M	$0.00	$0.00	$400.0K	$400.0K
YoY Change	-11.4%	-12.81%	-14.18%	-5.16%	-54.53%	-23.15%	-21.86%	-15.59%	-8.72%	7.57%	45.17%	10.7%	14.79%	34.8%	87.34%	222.45%	75.0%	-6.67%			-100.0%	0.0%
Total Assets	$16.47M	$17.78M	$22.65M	$21.12M	$22.24M	$45.38M	$59.95M	$78.52M	$96.51M	$121.1M	$157.6M	$163.2M	$156.4M	$131.8M	$100.9M	$75.50M	$43.70M	$28.50M	$17.50M	$0.00	$0.00	$400.0K	$400.0K
YoY Change
Accounts Payable	$966.4K	$667.1K	$926.8K	$1.235M	$1.366M	$1.061M	$1.141M	$3.060M	$2.439M	$2.551M	$1.900M	$2.800M	$3.100M	$4.900M	$4.000M	$1.000M	$300.0K	$500.0K	$700.0K	$100.0K	$0.00	$0.00	$0.00
YoY Change	44.87%	-28.02%	-24.93%	-9.64%	28.79%	-7.03%	-62.71%	25.46%	-4.37%	34.25%	-32.14%	-9.68%	-36.73%	22.5%	300.0%	233.33%	-40.0%	-28.57%	600.0%
Accrued Expenses	$376.6K	$445.3K	$383.7K	$229.4K	$281.2K	$310.8K	$276.4K	$139.8K	$143.4K	$269.9K	$300.0K	$2.600M	$3.300M	$2.500M	$1.600M	$1.200M	$600.0K	$300.0K	$600.0K		$100.0K	$0.00	$0.00
YoY Change	-15.43%	16.03%	67.25%	-18.41%	-9.53%	12.46%	97.65%	-2.5%	-46.86%	-10.04%	-88.46%	-21.21%	32.0%	56.25%	33.33%	100.0%	100.0%	-50.0%
Deferred Revenue
YoY Change
Short-Term Debt	$1.971M	$6.241M	$4.329M	$2.038M	$109.9K	$1.274M	$709.8K	$1.089M	$4.622M	$4.887M	$4.900M	$4.800M	$3.900M	$3.800M	$3.800M	$2.500M	$2.700M	$6.500M	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-68.42%	44.17%	112.37%	1754.56%	-91.37%	79.48%	-34.81%	-76.44%	-5.43%	-0.26%	2.08%	23.08%	2.63%	0.0%	52.0%	-7.41%	-58.46%
Long-Term Debt Due			$0.00	$2.299M	$2.150M	$2.181M	$2.305M	$1.440M	$1.541M	$1.629M											$600.0K	$400.0K	$400.0K
YoY Change			-100.0%	6.92%	-1.43%	-5.38%	60.08%	-6.52%	-5.43%												50.0%	0.0%
Total Short-Term Liabilities	$6.821M	$12.74M	$10.51M	$11.40M	$10.05M	$10.05M	$9.227M	$10.40M	$12.79M	$14.17M	$12.00M	$14.60M	$13.80M	$12.80M	$10.50M	$5.600M	$3.900M	$7.600M	$5.800M	$100.0K	$900.0K	$700.0K	$700.0K
YoY Change	-46.46%	21.17%	-7.81%	13.52%	-0.06%	8.93%	-11.26%	-18.71%	-9.74%	18.1%	-17.81%	5.8%	7.81%	21.9%	87.5%	43.59%	-48.68%	31.03%	5700.0%	-88.89%	28.57%	0.0%
Long-Term Debt	$1.412M	$0.00	$5.250M	$904.2K	$2.150M	$4.363M	$6.916M	$8.641M	$10.78M	$11.40M	$12.50M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$300.0K	$300.0K
YoY Change		-100.0%	480.6%	-57.95%	-50.71%	-36.92%	-19.96%	-19.88%	-5.43%	-8.77%										-100.0%	-66.67%	0.0%
Other Long-Term Liabilities	$39.91K	$0.00	$44.18K	$0.00	$48.70K					$0.00			$0.00	$900.0K	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change		-100.0%		-100.0%									-100.0%
Total Long-Term Liabilities	$1.452M	$0.00	$5.294M	$904.2K	$2.199M	$4.363M	$6.916M	$8.641M	$10.78M	$11.40M	$12.50M	$0.00	$0.00	$900.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$300.0K	$300.0K
YoY Change		-100.0%	485.49%	-58.88%	-49.6%	-36.92%	-19.96%	-19.88%	-5.43%	-8.77%			-100.0%							-100.0%	-66.67%	0.0%
Total Liabilities	$9.015M	$13.49M	$16.63M	$13.11M	$13.00M	$15.18M	$16.88M	$19.61M	$23.87M	$28.34M	$24.70M	$14.70M	$13.90M	$13.80M	$10.50M	$5.600M	$3.900M	$7.700M	$5.800M	$100.0K	$1.000M	$1.000M	$1.000M
YoY Change	-33.2%	-18.87%	26.83%	0.89%	-14.37%	-10.09%	-13.92%	-17.85%	-15.78%	14.75%	68.03%	5.76%	0.72%	31.43%	87.5%	43.59%	-49.35%	32.76%	5700.0%	-90.0%	0.0%	0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	3.384M shares	5.257M shares	4.613M shares
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $3.7544 Million

About CHINA PHARMA HOLDINGS, INC.

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 231 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Industry: Pharmaceutical Preparations Peers: China SXT Pharmaceuticals, Inc. SUNWIN STEVIA INTERNATIONAL, INC. BGM Group Ltd. Universe Pharmaceuticals INC